The United States has quietly slashed HIV funding in South Africa, a move that sources say will leave a gaping hole in the country's treatment programmes. The decision, confirmed by internal documents obtained by this paper, comes as the UK announces a new health pledge to Commonwealth nations, raising questions about who really controls the levers of global health aid.
South Africa, home to the world's largest HIV epidemic, has relied heavily on the US President's Emergency Plan for AIDS Relief (PEPFAR) for years. But recent budget allocations show a reduction of nearly 20 per cent in direct HIV funding to the country, with officials citing a need to 'rebalance priorities'. Critics call it a death sentence for thousands.
Enter the UK. Hours after the US cuts were reported, the British government unveiled a £150 million Commonwealth Health Initiative, promising to 'support vulnerable communities' in Africa. The timing is no coincidence. A senior Whitehall source told me: 'We knew this was coming. The Americans are pulling back, and someone has to fill the void.'
But the devil is in the details. The UK pledge is not new money. It is a repackaging of existing overseas development assistance, shuffled from other programmes. And unlike PEPFAR, which funnelled funds directly to clinics and treatment centres, the Commonwealth initiative will be channelled through multilateral bodies and private foundations. That means more layers, more bureaucracy, and more opportunities for the money to disappear.
I have seen the spreadsheets. The UK's pledge, while welcome, covers less than half of what the US has cut. And the conditions attached are strict: recipient countries must demonstrate 'good governance' and 'transparency'. South Africa, with its crumbling health infrastructure and history of corruption, may not qualify for a penny.
This is not charity. It is a power play. The US withdrawal is a signal that global health is no longer a Cold War priority. The UK's intervention is a bid to maintain influence in a region where China is increasingly dominant. But the people who will suffer are the ones already living on the edge: the mothers, the children, the millions who depend on antiretroviral drugs to survive.
One doctor in Soweto told me: 'We don't care where the money comes from. We just need it to keep coming.' But the money is not coming. At least not in the way it used to.
Let me be clear. The US has not abandoned South Africa entirely. There are still programmes for tuberculosis and malaria. But HIV funding, the backbone of the country's health system, is being gutted. And the UK's promise, however noble, is a drop in the ocean.
I have tracked the money for two decades. It always leads to the same place: a boardroom where decisions are made without any thought for the bodies on the ground. The cuts were signed off in Washington. The pledge was announced in London. But the consequences will be felt in Johannesburg, Durban, and Cape Town.
This is not a story about generosity. It is a story about power, about who decides who lives and who dies. And as always, the people who pay the price are the ones with no seat at the table.
